KALA BIO
KALA
37 hedge funds and large institutions have $196M invested in KALA BIO in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
71% more capital inflows, than outflows
Capital inflows: $16.5M | Capital outflows: $9.7M
1.98% more ownership
Funds ownership: 67.96% → 69.94% (+2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less funds holding
Funds holding: 38 → 37 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
96% less call options, than puts
Call options by funds: $7K | Put options by funds: $197K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$2.66M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.13M |
| 4 |
Teachers Advisors
New York
|
+$1.6M |
| 5 |
Caxton Corporation
Princeton,
New Jersey
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$2.13M |
| 2 |
Broadfin Capital
New York
|
-$1.66M |
| 3 |
Renaissance Technologies
New York
|
-$1.6M |
| 4 |
Oxford Asset Management
Oxford,
United Kingdom
|
-$1.07M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$533K |
KALA Hedge Fund Activity: Q1 2019 in Review
37 of the 4,635 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2019, worth a combined $196M — up 74% from $112M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of KALA and 5 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, adding an estimated $4.8M. The largest seller was Deutsche Bank, exiting entirely with an estimated $2.13M sold.
- 37 institutional investors held KALA BIO (KALA) as of Q1 2019, down from 38 in Q4 2018.
- Funds reported $196M of KALA BIO stock for Q1 2019, up 74% quarter-over-quarter.
- 5 funds opened new KALA BIO positions in Q1 2019 and 6 closed out, a net change of -1 holder.
- The largest KALA BIO buyer in Q1 2019 was Millennium Management, an estimated $4.8M added.
- The largest KALA BIO seller in Q1 2019 was Deutsche Bank, an estimated $2.13M sold.
Based on aggregated 13F filings for Q1 2019.